No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
287 |
4. Check minimum number of eventsNone |
287 |
5. Include endpointsNone |
287 |
6. Filter based on genotype QC (FinnGen only) |
287 |
Control definitions (FinnGen only)
- Control exclude
- N14_FEMALEGENNONINF
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- N80
- Name in latin
- Endometriosis tubae uterinae
Similar endpoints
↥List of similar endpoints to
Endometriosis of fallopian tube
based on the number of shared cases.
Similar with more cases:
- Endometriosis ASRM stages 1,2
- Endometriosis
- Noninflammatory disorders of female genital tract
- Genitourinary diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1739 | 1739 | - |
| Only index persons | 1696 | 1696 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | - |
| Only index persons | 0.06 | 0.06 | - |
| Median age at first event (years) | |||
| Whole population | - | 38.90 | - |
| Only index persons | - | 38.71 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 287 | 287 | - |
| Unadjusted period prevalence (%) | 0.10 | 0.10 | - |
| Median age at first event (years) | 37.76 | 37.76 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 267
- Matched controls
- 2670
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N80.2
ICD-10 Finland
Endometriosis of fallopian tube
+∞
294.0
225
*
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
148.6
100.7
102
11
N80.1
ICD-10 Finland
Endometriosis of ovary
+∞
95.7
86
*
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
+∞
90.9
82
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
8.4
54.6
164
427
N80.9
ICD-10 Finland
Endometriosis, unspecified
328.8
54.3
53
*
6172A
ICD-9 Finland
Endometriosis of Fallopian tube
+∞
45.1
42
*
N80.0
ICD-10 Finland
Endometriosis of uterus
+∞
44.0
41
*
N97.9
ICD-10 Finland
Female infertility, unspecified
134.6
43.2
45
*
N80.4
ICD-10 Finland
Endometriosis of rectovaginal septum and vagina
+∞
36.3
34
*
N97.8
ICD-10 Finland
Female infertility of other origin
+∞
31.9
30
*
N95.1
ICD-10 Finland
Menopausal and female climacteric states
+∞
28.7
27
*
G03GA06
ATC
follitropin beta; parenteral
34.4
28.0
36
12
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
4.8
27.5
115
363
JAL21
NOMESCO Finland
Laparoscopic excision or destruction of lesion of peritoneum
299.5
27.2
27
*
LAA10
NOMESCO Finland
Percutaneous or transvaginal puncture and recovery of oocyte
299.5
27.2
27
*
JAH01
NOMESCO Finland
Laparoscopy
14.0
26.5
46
39
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
19.0
24.9
38
23
G03GA01
ATC
chorionic gonadotrophin; parenteral
18.2
24.5
38
24
LBF01
NOMESCO Finland
Laparoscopic perfusion of Fallopian tube
+∞
24.3
23
*
L02AE02
ATC
leuprorelin; implant, parenteral
30.0
24.2
32
12
N70.1
ICD-10 Finland
Chronic salpingitis and oophoritis
51.9
23.8
28
6
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
10.7
23.8
47
52
H01CA02
ATC
nafarelin; nasal
25.8
23.2
32
14
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
13.2
22.6
40
35
N80.5
ICD-10 Finland
Endometriosis of intestine
+∞
22.2
21
*
LAF01
NOMESCO Finland
Laparoscopic unilateral salpingo-oophorectomy
42.6
22.2
27
7
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
6.0
22.2
67
142
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
3.6
21.6
161
799
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.6
21.4
138
609
G03GA02
ATC
human menopausal gonadotrophin; parenteral
19.7
20.1
30
17
6171A
ICD-9 Finland
Endometriosis of ovary
+∞
20.0
19
*
N84.0
ICD-10 Finland
Polyp of corpus uteri
79.4
20.0
22
*
Z35.0
ICD-10 Finland
Supervision of pregnancy with history of infertility
37.4
19.2
24
7
LAC01
NOMESCO Finland
Laparoscopic excision of ovarian cyst
75.5
19.0
21
*
LBE01
NOMESCO Finland
Laparoscopic salpingectomy
19.4
18.7
28
16
1413
FHL
Laparoscopy and other therapeutic procedure
27.4
18.6
25
10
TLW12
NOMESCO Finland
Insertion of frozen embryo
+∞
17.9
17
*
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
6.4
17.8
49
91
LCA06
NOMESCO Finland
Biopsy of endometrium
7.9
17.5
41
60
N94.5
ICD-10 Finland
Secondary dysmenorrhoea
53.7
17.2
20
*
TLW10
NOMESCO Finland
Transfer of fresh embryo
+∞
16.8
16
*
N80.89
ICD-10 Finland
Endometriosis with other specified or multiple localization
+∞
16.8
16
*
LAC21
NOMESCO Finland
Laparoscopic destruction of lesion of ovary
50.8
16.2
19
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.1
16.0
122
570
N97.1
ICD-10 Finland
Female infertility of tubal origin
+∞
14.7
14
*
N80.8
ICD-10 Finland
Other endometriosis
+∞
14.7
14
*
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
13.7
14.7
25
20
G03DC03
ATC
lynestrenol; oral
14.5
14.5
24
18
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
4.4
14.2
55
149
N81.6
ICD-10 Finland
Rectocele
25.4
14.0
19
8
TLC00
NOMESCO Finland
Insertion of intrauterine device
6.8
13.7
35
58
N80.81
ICD-10 Finland
Endometriosis in sacrouteral ligament
+∞
13.7
13
*
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
+∞
13.7
13
*
6146A
ICD-9 Finland
Inflammatory disease of ovary, Fallopian tube, pelvic cellular tissue and peritoneum, Pelvic peritoneal adhesions, female
147.1
13.6
14
*
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
27.4
13.5
18
7
1410
FHL
Laparoscopy
13.1
13.4
23
19
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
16.2
13.3
21
14
G03DA04
ATC
progesterone; systemic, rectal, vaginal
8.8
13.2
28
35
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
20.3
13.1
19
10
N99.4
ICD-10 Finland
Postprocedural pelvic peritoneal adhesions
52.7
13.0
15
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
12.9
86
357
B02AA02
ATC
tranexamic acid; systemic
3.6
12.6
62
206
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
21.3
12.6
18
9
121
Kela drug reimbursment
Severe hypofunction of sexual glands
25.8
12.6
17
7
LEF13
NOMESCO Finland
Colpoperineoplasty and vaginal hysterectomy
+∞
12.6
12
*
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
+∞
12.6
12
*
LA2AE
NOMESCO Finland
Ultrasound examination of ovarian cyst
+∞
12.6
12
*
N80
ICD-10 Finland
Endometriosis
136.1
12.5
13
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
5.0
12.4
41
94
LAC00
NOMESCO Finland
Excision of ovarian cyst
68.0
11.7
13
*
M01AE02
ATC
naproxen; oral, rectal
2.5
11.5
173
1133
ZXD10
NOMESCO Finland
Scheduled procedure
2.6
11.5
115
605
Z31.2
ICD-10 Finland
In vitrofertilization
+∞
11.5
11
*
6173B
ICD-9 Finland
Endometriosis of pelvic peritoneum[ENDOMETRIOSIS RETROUTERINA]
+∞
11.5
11
*
N83.1
ICD-10 Finland
Corpus luteum cyst
+∞
11.5
11
*
6173A
ICD-9 Finland
Endometriosis of pelvic peritoneum[ENDOMETRIOSIS SEROSAE PELVIS]
+∞
11.5
11
*
8341
FHL
Colony removal or incineration
+∞
11.5
11
*
LAA06
NOMESCO Finland
Transvaginal puncture of ovarian cyst
125.1
11.5
12
*
G03GA05
ATC
follitropin alfa; parenteral
13.5
11.3
19
15
LCD00
NOMESCO Finland
Hysterectomy
6.5
10.9
28
47
N73.6
ICD-10 Finland
Female pelvic peritoneal adhesions
29.4
10.8
14
5
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.0
10.8
44
124
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
8.3
10.6
23
30
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
114.3
10.5
11
*
LCF01
NOMESCO Finland
Laparoscopic excision of lesion of parametrium
+∞
10.5
10
*
6202X
ICD-9 Finland
Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Other and unspecified ovarian cyst
+∞
10.5
10
*
P01AB01
ATC
metronidazole; oral, rectal
2.4
10.2
132
783
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
10.1
9.9
19
20
N81.1
ICD-10 Finland
Cystocele
27.2
9.9
13
5
L02AE03
ATC
goserelin; implant
27.2
9.9
13
5
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
57.1
9.7
11
*
N02AX02
ATC
tramadol; systemic, rectal
2.4
9.7
113
630
TLW00
NOMESCO Finland
Insemination
+∞
9.4
9
*
N02BE01
ATC
paracetamol; systemic, rectal
2.9
9.4
234
1891
8113
FHL
Fractional scraping
14.4
9.3
15
11
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
7.9
9.1
20
27
LCA13
NOMESCO Finland
Curettage of cervix and body of uterus
38.1
9.1
11
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.6
8.9
41
128
M01AG02
ATC
tolfenamic acid; oral, rectal
2.6
8.8
70
316
XLA10
NOMESCO Finland
NA
5.5
8.7
25
49
N93.8
ICD-10 Finland
Other specified abnormal uterine and vaginal bleeding
92.8
8.5
9
*
N87.0
ICD-10 Finland
Mild cervical dysplasia
92.8
8.5
9
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
8.4
68
309
N97.4
ICD-10 Finland
Female infertility associated with male factors
+∞
8.4
8
*
LCA30
NOMESCO Finland
Transfer of oocyte or embryo to uterus in assisted fertilisation
+∞
8.4
8
*
LEF00
NOMESCO Finland
Anterior colporraphy with sutures for primary cystocele
+∞
8.4
8
*
LA2JE
NOMESCO Finland
Follow-up of menstrual cycle with repeated measurement of ovarian cyst
+∞
8.4
8
*
J02AC01
ATC
fluconazole; systemic
2.1
8.2
151
1014
H01CC01
ATC
ganirelix; parenteral
12.2
8.2
14
12
N83.0
ICD-10 Finland
Follicular cyst of ovary
34.5
8.1
10
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
4.3
8.0
29
74
N95.0
ICD-10 Finland
Postmenopausal bleeding
11.3
7.9
14
13
R2110
NOMESCO Finland
Giving the first information
4.1
7.9
30
80
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.6
7.8
26
61
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
13.9
7.5
12
9
R51.80
ICD-10 Finland
Headache
2.7
7.4
52
218
6289A
ICD-9 Finland
Infertility, female, Of unspecified origin[STERILITAS ET INFERTILITAS MULIERIS NUD PRIM]
+∞
7.3
7
*
6170A
ICD-9 Finland
Endometriosis of uterus
+∞
7.3
7
*
6266A
ICD-9 Finland
Disorders of menstruation and other abnormal bleeding from female genital tract, Metrorrhagia
+∞
7.3
7
*
ZXE00
NOMESCO Finland
One hour or less
2.1
7.3
109
660
8201
FHL
Ovarian preservation exploration and related procedures, eg resection, enucleation or ovariolysis
16.3
7.3
11
7
UJF32
NOMESCO Finland
Coloscopy
2.5
7.2
61
282
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
5.8
7.1
19
35
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
4.4
7.0
24
58
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
6.4
6.9
17
28
ULC02
NOMESCO Finland
Hysteroscopy
9.7
6.9
13
14
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
6.5
55
254
J01DB01
ATC
cefalexin; oral
2.3
6.4
225
1870
B01AB05
ATC
enoxaparin; parenteral
2.2
6.4
78
429
N94.6
ICD-10 Finland
Dysmenorrhoea, unspecified
11.4
6.4
11
10
L02AE01
ATC
buserelin; implant, nasal, parenteral
18.5
6.3
9
5
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
7.3
6.3
14
20
G03GA04
ATC
urofollitropin; parenteral
+∞
6.3
6
*
62800
ICD-8 Finland
Sterility, female, Sterilitas primaria
+∞
6.3
6
*
LAD00
NOMESCO Finland
Partial excision of ovary
+∞
6.3
6
*
N83.8
ICD-10 Finland
Other noninflammatory disorders of ovary, fallopian tube and broad ligament
+∞
6.3
6
*
N97.0
ICD-10 Finland
Female infertility associated with anovulation
+∞
6.3
6
*
ULA02
NOMESCO Finland
Kolposcopy
3.0
6.3
35
126
G44.2
ICD-10 Finland
Tension-type headache
2.7
6.2
42
171
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
4.4
6.2
21
51
D25.0
ICD-10 Finland
Submucous leiomyoma of uterus
7.0
6.1
14
21
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.6
6.1
47
206
J01FA10
ATC
azithromycin; systemic
1.9
6.0
169
1268
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021601) Nitrite [Presence] in Urine by Test strip
162
1062
2.21
9.76
5.3
4.4
estimate
0.0
0.0
0.50
37
189
(3009261) Glucose [Presence] in Urine by Test strip
162
1073
2.17
9.37
4.1
3.3
estimate
0.0
0.0
0.00
39
186
(40768804) Tissue Pathology biopsy report
140
886
2.13
9.00
2.2
1.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
158
1063
2.08
8.47
4.1
3.3
estimate
0.0
0.0
0.00
39
192
(3002256) Pathology report gross observation
56
256
2.48
7.74
1.3
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
96
554
2.10
7.61
4.3
3.9
estimate
0.1
0.0
0.42
37
184
(3041096) Erythrocytes [Presence] in Urine by Automated
97
580
2.02
6.87
3.6
2.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
108
674
1.97
6.75
2.9
3.0
ng/l
19.3
24.1
0.32
49
365
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
237
1947
2.25
6.44
5.0
4.2
pmol/l
14.6
14.5
0.21
227
1811
(3044889) 12 lead EKG panel
196
1507
1.95
6.36
3.5
3.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
123
815
1.89
6.34
4.1
3.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
57
289
2.21
6.16
1.6
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
101
640
1.89
5.89
2.5
2.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
158
1151
1.83
5.88
4.8
4.6
mmol/l
6.3
6.5
1.42
149
1052
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
31
121
2.75
5.85
1.7
1.7
u/l
3811.9
4298.0
—
10
48
(3022145) Colonoscopy Study observation
45
211
2.34
5.83
1.2
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
196
1530
1.89
5.80
4.7
3.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
60
324
2.08
5.50
1.8
1.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
138
983
1.78
5.38
4.9
3.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
98
631
1.84
5.35
2.8
2.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
107
711
1.81
5.25
4.0
3.0
e6/l
98.2
78.5
0.14
69
452
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
96
619
1.83
5.19
2.6
2.1
u/l
52.6
57.0
0.77
87
570
(40767503) Oxygen content in Capillary blood by calculation
12
27
4.59
5.08
2.6
2.0
%
16.0
16.6
—
6
15
(3021879) Hepatitis B virus core Ab [Presence] in Serum
35
156
2.42
5.07
1.4
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
107
718
1.78
5.04
8.7
6.7
inr
1.1
1.1
0.20
41
236
(3015736) pH of Urine
118
821
1.74
4.87
3.5
3.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
89
573
1.80
4.78
3.5
2.7
e6/l
15.4
61.9
1.02
64
414
(3023368) Bacteria identified in Blood by Culture
72
437
1.86
4.66
4.7
3.9
—
—
—
0
0
(4281824)
10
21
4.90
4.56
1.3
1.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
256
2257
2.24
4.49
5.7
4.8
mu/l
1.6
1.8
2.24
243
2103
(3030467) Casts [#/volume] in Urine by Automated count
83
533
1.78
4.46
3.2
2.6
e6/l
0.3
0.5
0.54
59
384
(36304419) Bacteria [Presence] in Urine
82
525
1.79
4.45
3.1
2.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
64
380
1.88
4.42
2.9
2.3
e6/l
6.5
7.6
0.35
57
334
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
13
35
3.84
4.41
1.2
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
40
201
2.15
4.39
1.7
1.8
—
—
—
0
0
(3026782) Osmolality of Urine
60
350
1.90
4.37
3.0
2.6
mosm/kgh2o
477.1
503.8
0.46
52
300
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
143
1079
1.65
4.18
5.1
5.7
umol/l
9.3
10.4
0.68
137
1020
(40768797) Stomach Pathology biopsy report
47
262
1.95
3.90
1.2
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
129
964
1.61
3.82
9.8
8.0
e9/l
0.0
0.0
0.61
104
795
(3001122) Ferritin [Mass/volume] in Serum or Plasma
146
1128
1.60
3.74
3.3
2.7
ug/l
87.0
80.5
0.22
134
1070
(3007164) IgA [Mass/volume] in Serum or Plasma
76
498
1.72
3.74
1.6
1.4
g/l
2.2
2.3
0.27
41
313
(40761536) Microorganisms panel - Urine sediment
36
186
2.07
3.68
3.9
3.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
120
889
1.60
3.64
5.6
5.3
mmol/l
1.2
1.2
0.18
111
815
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
77
510
1.70
3.63
1.6
1.6
mg/l
0.5
0.9
2.76
51
383
(3017143) Hepatitis C virus Ab [Presence] in Serum
46
261
1.91
3.62
1.4
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
32
162
2.10
3.45
1.6
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
200
1685
1.62
3.42
4.2
3.9
mm/h
11.0
11.5
0.24
191
1567
(3003327) Ova and parasites identified in Stool by Light microscopy
20
83
2.52
3.39
1.5
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
247
2203
1.87
3.38
12.3
9.4
ml/min/173m2
85.8
86.0
0.04
218
1772
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
129
986
1.56
3.36
7.1
6.1
mmol/l
1.2
1.2
0.05
108
831
(3048689) Calprotectin [Mass/mass] in Stool
50
299
1.81
3.35
2.2
2.4
ug/g
118.9
124.6
0.04
40
231
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
22
97
2.37
3.29
1.5
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
87
614
1.60
3.16
4.0
3.2
ph
7.4
7.4
0.41
27
111
(3025941) Bacteria identified in Stool by Culture
28
142
2.08
3.02
1.4
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
81
571
1.58
2.93
1.2
1.2
u/ml
2.3
1.2
0.57
30
148
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
197
1682
1.55
2.92
7.3
6.7
u/l
73.2
75.6
0.39
184
1582
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
70
479
1.61
2.86
2.3
2.1
mg/l
2.6
2.8
0.50
60
418
(3018677) aPTT in Platelet poor plasma by Coagulation assay
45
275
1.75
2.80
2.0
1.9
s
29.1
29.2
0.02
45
267
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
134
2.03
2.70
1.5
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
61
412
1.61
2.62
1.6
1.6
pmol/l
464.2
45882789.7
0.80
55
340
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
11
5.54
2.55
1.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
208
1820
1.52
2.55
3.6
3.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
29
159
1.92
2.55
1.6
1.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
46
291
1.69
2.54
2.6
2.2
umol/l
13.7
14.1
0.14
41
263
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
259
2391
1.85
2.52
15.5
10.6
mg/l
21.3
20.1
0.29
218
1767
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
46
292
1.69
2.51
3.1
2.5
e6/l
1.9
4.5
2.09
16
146
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
26
3.54
2.50
1.0
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
109
847
1.46
2.44
5.2
4.6
g/l
36.3
36.4
0.07
100
800
(3037522) Nuclear Ab [Titer] in Serum
52
344
1.62
2.42
1.4
1.3
titre
277.1
862.2
3.54
14
74
(40761511) CBC panel - Blood by Automated count
271
2545
2.16
2.42
13.7
10.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
12
5.08
2.41
1.0
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
12
5.08
2.41
1.0
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
27
3.41
2.41
1.1
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
27
3.41
2.41
1.1
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
92
693
1.48
2.41
5.3
6.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
40
2.82
2.40
1.3
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
70
498
1.54
2.40
3.9
3.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
13
52
2.57
2.39
1.2
1.3
ug/g
324.8
306.4
—
6
25
(3022096) Basophils/100 leukocytes in Blood
119
947
1.44
2.33
5.3
6.0
%
0.7
0.7
0.10
112
883
(3019069) Monocytes/100 leukocytes in Blood
123
986
1.43
2.31
5.7
6.3
%
7.7
8.1
0.70
118
927
(3006504) Eosinophils/100 leukocytes in Blood
122
980
1.43
2.25
5.4
6.0
%
2.7
2.6
0.17
114
916
(3023323) Follitropin [Units/volume] in Serum or Plasma
31
182
1.79
2.22
1.5
1.4
iu/l
28.4
28.8
0.02
24
155
(1616796) Gas panel - Central venous blood
10
36
2.84
2.22
2.6
2.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
9
5.63
2.22
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
9
5.63
2.22
1.0
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
185
1607
1.43
2.16
3.1
2.7
u/l
37.6
39.8
0.20
172
1519
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
43
2.62
2.12
1.2
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
19
96
2.05
2.11
2.3
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
32
193
1.74
2.10
2.9
3.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
9
31
2.96
2.09
1.6
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
22
118
1.94
2.08
9.0
8.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
31
186
1.75
2.08
7.4
10.7
mmol/l
1.2
1.5
0.30
20
150
(3001604) Monocytes [#/volume] in Blood
130
1070
1.39
2.03
5.2
6.0
e9/l
0.5
0.5
0.22
109
942
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
8
26
3.13
2.03
1.3
1.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
121
985
1.39
2.02
2.2
2.2
nmol/l
79.1
75.9
0.64
112
912
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
76
569
1.46
2.02
1.5
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
57
2.34
2.01
1.4
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
63
456
1.49
1.98
4.6
3.5
kg/l
1.0
1.0
0.15
14
61
(3006315) Basophils [#/volume] in Blood
130
1074
1.38
1.97
5.2
6.1
e9/l
0.0
0.0
0.56
109
943
(3002030) Lymphocytes/100 leukocytes in Blood
125
1027
1.38
1.96
5.5
6.0
%
29.5
29.4
0.05
120
963
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
11
4.60
1.95
1.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
19
100
1.96
1.90
2.0
1.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
72
2.14
1.90
1.1
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
65
478
1.47
1.89
2.7
1.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
47
323
1.54
1.88
2.8
2.3
e6/l
0.8
1.2
1.03
19
178
(46235355) HIV 1 and 2 tests - Meaningful Use set
70
524
1.44
1.85
2.0
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
270
2562
1.91
1.85
10.0
8.9
u/l
23.7
23.9
0.11
262
2478
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
73
2.11
1.84
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
15
74
2.08
1.78
1.1
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
134
1126
1.36
1.78
5.2
6.4
e9/l
0.2
0.2
0.88
115
999
(3019198) Lymphocytes [#/volume] in Blood
132
1108
1.35
1.76
5.3
6.0
e9/l
1.9
2.0
0.91
115
992
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
72
550
1.41
1.70
1.7
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
83
1.98
1.68
1.3
1.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
7
25
2.84
1.66
1.1
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
45
316
1.50
1.64
1.4
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
32
2.54
1.61
2.5
7.4
—
123.0
—
0
5
(3019230) Fractional oxyhemoglobin in Venous blood
7
26
2.73
1.59
1.3
1.9
%
51.3
61.7
—
7
26
(3019060) Gas panel - Arterial blood
19
107
1.83
1.59
5.4
11.2
—
—
—
0
0
(44813793)
6
20
3.04
1.59
1.0
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
6
20
3.04
1.59
1.3
1.2
mu/l
6.1
39.3
—
6
20
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
40
277
1.52
1.56
1.7
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
90
725
1.35
1.53
3.1
3.6
mmol/l
2.3
2.4
0.20
75
664
(3021901) Oxygen saturation in Capillary blood
7
27
2.63
1.52
3.3
1.9
—
—
—
0
0
(1002224) Polysomnography panel
18
102
1.82
1.48
1.1
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
38
2.41
1.47
1.2
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
110
1.78
1.47
1.4
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
31
206
1.57
1.45
1.1
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
71
556
1.37
1.44
3.9
4.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
22
2.76
1.44
1.0
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
42
300
1.47
1.42
1.9
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
29
2.45
1.40
1.4
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
17
2.97
1.36
2.4
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
12
61
2.01
1.35
2.2
2.6
ug/l
0.6
2.0
0.87
12
54
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
27
177
1.58
1.35
2.4
2.3
—
18.2
—
0
13
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
54
2.08
1.34
2.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
57
436
1.38
1.33
1.8
1.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
14
76
1.89
1.32
2.1
2.4
%
1.1
1.3
0.26
14
76
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
24
2.53
1.31
2.0
2.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
23
146
1.63
1.30
3.3
2.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
25
2.43
1.25
1.2
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
26
2.33
1.19
1.7
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
26
2.33
1.19
1.3
3.5
u/ml
22.7
68.3
—
6
26
(3015171) Extractable nuclear Ab [Units/volume] in Serum
18
110
1.68
1.18
1.3
1.2
—
1.2
—
0
9
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
58
454
1.35
1.18
1.3
1.2
u/ml
6.5
12.0
0.44
33
173
(40768793) Breast Pathology biopsy report
15
87
1.76
1.17
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
20
2.53
1.15
1.2
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
53
412
1.35
1.13
2.4
2.9
ng/l
3490.6
1088.7
0.46
45
353
(3025130) Human papilloma virus identified in Specimen
7
30
2.37
1.13
2.0
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
32
2.22
1.09
1.4
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
144
1284
1.24
1.05
8.1
9.4
e9/l
3.7
4.0
0.92
124
1128
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
249
2371
1.38
1.05
4.0
3.6
mmol/l
1.6
1.6
0.70
233
2224
(4010399)
19
124
1.57
0.99
1.4
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
27
191
1.46
0.99
1.9
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
17
108
1.61
0.99
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
36
1.97
0.97
1.1
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
36
1.97
0.97
1.1
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
249
2378
1.36
0.96
4.1
3.7
mmol/l
5.0
4.9
0.82
233
2234
(3020891) Body temperature
11
62
1.81
0.95
8.5
5.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
13
78
1.70
0.93
1.5
1.8
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
6
28
2.17
0.92
1.2
1.2
nmol/l
0.5
0.6
—
6
28
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
6
28
2.17
0.92
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
22
152
1.48
0.91
1.3
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
26
186
1.44
0.91
1.8
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
29
2.09
0.90
1.5
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
42
1.93
0.89
3.1
4.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
21
145
1.48
0.87
4.8
3.9
%
1.4
0.5
—
7
34
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
32
240
1.38
0.87
1.7
2.4
umol/l
7.7
4.8
0.58
26
203
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
239
2279
1.29
0.86
3.7
3.3
mmol/l
1.3
1.2
0.75
221
2127
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
45
1.80
0.85
1.4
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
34
259
1.35
0.84
2.4
2.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
16
105
1.55
0.83
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
11
65
1.72
0.83
1.5
1.7
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
15
97
1.58
0.83
10.7
9.6
%
0.9
0.7
0.69
15
97
(3025159) Blasts/100 leukocytes in Blood
21
147
1.46
0.83
5.3
4.3
%
0.0
2.3
—
9
34
(3007853) Bacteria identified in Skin by Aerobe culture
30
225
1.37
0.82
2.0
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
31
235
1.36
0.80
6.2
6.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
267
0.69
0.79
1.7
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
33
1.84
0.79
1.7
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
33
1.84
0.79
1.0
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
26
0.00
0.79
0.0
1.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
21
149
1.44
0.78
5.3
4.3
%
0.3
0.1
—
10
39
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
10
59
1.72
0.77
3.1
2.9
u/ml
25.6
30.1
—
10
51
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
11
67
1.67
0.76
1.4
1.9
%
194.6
176.5
0.30
11
62
(3019832) Treponema pallidum Ab [Presence] in Serum
39
309
1.30
0.76
1.6
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
54
1.69
0.75
2.0
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
22
159
1.42
0.75
5.5
4.2
%
1.6
0.6
—
10
43
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
27
203
1.36
0.74
1.3
1.2
iu/ml
111.0
164.5
—
10
95
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
25
2.02
0.73
1.0
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
58
487
1.24
0.72
1.3
1.3
iu/ml
63.0
28.2
0.38
21
151
(3012544) pH of Venous blood
21
152
1.41
0.71
7.6
3.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
26
1.94
0.71
1.0
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
88
773
1.20
0.70
1.8
1.8
pmol/l
96.2
97.3
0.09
39
395
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
85
1.55
0.70
2.2
2.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
12
77
1.58
0.69
2.2
1.8
iu/l
1.6
5.2
—
5
26
(3003694) ABO and Rh group [Type] in Blood
77
669
1.21
0.69
1.5
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
42
1.68
0.69
1.1
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
42
1.68
0.69
1.1
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
43
351
1.26
0.68
4.9
3.4
ng/l
28.7
415.9
1.19
30
229
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
43
1.64
0.67
1.9
1.8
—
—
—
0
0
(4268621)
5
29
1.74
0.64
2.4
2.1
—
—
—
0
0
(3013512) EKG study
61
523
1.21
0.62
2.4
3.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
63
1.61
0.62
1.4
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
30
1.68
0.61
1.0
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
250
2420
1.26
0.61
4.7
4.1
mmol/l
3.0
2.9
0.69
235
2266
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.2
—
10.7
—
0
20
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
20
0.00
0.60
0.0
1.1
—
1.1
—
0
8
(3026493) Urate [Moles/volume] in Serum or Plasma
56
478
1.21
0.60
2.1
2.1
umol/l
303.3
4896.9
1.82
49
421
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
23
0.00
0.58
0.0
1.6
—
40.1
—
0
13
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
24
185
1.32
0.58
3.0
3.9
ug/l
4.5
6.0
0.33
16
146
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
35
1.73
0.58
1.2
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
12
81
1.50
0.58
1.0
1.0
—
1.0
—
0
14
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
14
98
1.45
0.57
11.4
9.5
%
1.6
1.4
0.70
14
98
(3028707) Methadone [Presence] in Urine by Screen method
6
36
1.68
0.57
12.0
2.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
89
0.55
0.57
1.6
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
37
304
1.25
0.56
1.6
1.6
nmol/l
1608.9
1178.8
0.96
28
225
(4034850)
9
61
1.49
0.54
11.0
6.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
62
1.47
0.53
1.6
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
13
180
0.71
0.53
1.4
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
9
63
1.44
0.53
3.9
15.5
mmol/l
1.4
1.2
—
9
58
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
63
1.44
0.53
1.0
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
135
1.36
0.52
1.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
40
1.51
0.52
1.0
1.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
11
75
1.49
0.51
8.4
3.4
mmol/l
23.9
24.5
0.34
11
69
(3036489) Thrombin time
13
94
1.40
0.46
1.5
1.6
s
21.9
20.9
0.21
13
80
(3009542) Hematocrit [Volume Fraction] of Blood
238
2309
1.18
0.46
15.0
12.0
%
39.3
39.3
0.06
180
1802
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
69
618
1.15
0.44
1.4
1.6
mmol/l
1.4
1.3
0.18
59
544
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
218
2104
1.15
0.43
5.4
4.5
mmol/mol
37.6
38.3
0.60
206
1967
(3004616) Nuclear Ab [Presence] in Serum
5
31
1.62
0.43
1.2
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
92
0.64
0.43
1.7
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
92
0.64
0.43
1.7
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
57
1.41
0.42
11.5
2.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
25
204
1.25
0.42
2.6
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
70
1.44
0.42
1.6
1.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
8
59
1.37
0.41
1.7
2.8
g/l
1.3
1.4
—
8
52
(3030981) Hyaline casts [#/volume] in Urine by Automated count
12
88
1.38
0.40
4.3
2.3
e6/l
0.3
0.3
0.11
12
83
(3000330) Specific gravity of Urine by Test strip
13
97
1.36
0.40
2.1
2.9
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
18
0.00
0.40
0.0
1.4
—
56.6
—
0
9
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
19
236
0.79
0.39
3.0
3.4
%
32.2
32.7
0.08
12
171
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
98
1.34
0.38
1.5
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
68
1.33
0.38
1.2
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
12
90
1.35
0.36
2.6
2.9
mmol/l
0.8
1.4
—
6
69
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.36
2.0
2.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
91
1.33
0.34
7.5
15.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.2
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
233
2272
1.14
0.33
4.4
3.7
mmol/l
5.6
5.7
0.94
222
2107
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
89
0.67
0.33
1.5
1.4
—
—
—
0
0
(3000492) Spirometry study
25
211
1.20
0.32
1.2
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
62
564
1.13
0.32
5.3
7.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
47
1.28
0.32
1.2
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
27
314
0.85
0.31
1.5
1.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
7
52
1.35
0.31
3.0
1.6
e6/l
479.3
77.7
—
7
44
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
7
52
1.35
0.31
2.9
1.6
e6/l
36.0
7.9
—
7
44
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
75
1.35
0.30
8.2
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
19
157
1.23
0.30
1.6
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
29
251
1.17
0.29
1.7
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
62
568
1.12
0.29
4.0
3.1
mmol/l
6.7
7.0
0.21
52
485
(3023511) Choriogonadotropin [Units/volume] in Urine
11
85
1.31
0.28
1.4
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
39
1.29
0.23
9.0
5.9
umol/l
401.8
367.5
—
5
33
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
5
40
1.25
0.22
1.6
2.4
nmol/l
1.2
0.7
—
5
33
(1761482) Bacteria [#/volume] in Urine by Culture
5
41
1.22
0.22
1.6
4.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
10
0.00
0.21
0.0
4.7
—
2244.0
—
0
10
(3047189) Immunofixation for 24 hour Urine
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
10
0.00
0.21
0.0
2.3
—
145.7
—
0
10
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
105
0.76
0.21
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
105
0.76
0.21
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
105
0.76
0.21
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
105
0.76
0.21
1.4
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
12
0.00
0.21
0.0
3.6
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
13
0.00
0.21
0.0
1.2
—
2238.4
—
0
7
(3023199) Leukocytes [#/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.1
—
1792.7
—
0
6
(3045788) Cell count panel - Pleural fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
10
80
1.26
0.20
1.4
1.8
%
89.6
94.4
—
10
71
(3016750) Collection duration of Urine
0
14
0.00
0.20
0.0
2.0
—
479.4
—
0
9
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
102
1.18
0.15
2.5
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
107
0.84
0.13
1.4
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
10
85
1.18
0.12
7.0
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
44
1.14
0.10
2.0
4.3
e9/l
3.8
4.4
—
5
44
(3003740) Influenza virus B Ag [Presence] in Specimen
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
45
1.11
0.10
2.6
4.5
%
57.2
57.6
—
5
45
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
46
1.09
0.09
1.8
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
20
184
1.09
0.09
1.5
1.6
—
—
—
0
0
(3019225) pH of Specimen
18
165
1.10
0.09
4.4
3.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
55
1.09
0.09
1.3
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
56
1.07
0.08
1.2
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
7
65
1.08
0.08
2.1
2.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
51
528
0.96
0.07
3.6
3.2
mg/l
163.0
420.3
0.58
30
320
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
17
181
0.94
0.05
2.6
2.8
ml/min/173m2
59.1
70.3
—
7
75
(3004588) Protein electrophoresis panel - Serum or Plasma
13
120
1.09
0.05
2.5
2.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
15
160
0.93
0.04
3.8
3.6
—
—
—
0
0
(4035726)
19
180
1.06
0.04
1.6
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
53
542
0.97
0.03
4.6
4.0
mg/mmol
42.3
11.8
0.65
31
323
(1761868) Lipid panel - Serum or Plasma
97
957
1.02
0.03
2.7
2.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
92
1.09
0.03
8.6
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
92
1.09
0.03
1.3
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
93
1.08
0.02
8.4
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
10
93
1.08
0.02
8.4
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
93
1.08
0.02
8.4
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
14
133
1.06
0.01
1.3
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
105
0.95
0.00
1.4
1.8
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
53.6
—
0
9
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
3.3
—
0
6
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
18.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.0
—
163.2
—
0
9
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
4.1
—
—
—
0
0
(3035880) pH of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
6.6
—
0
8
(3044290) Cell count panel - Cerebral spinal fluid
5
49
1.02
0.00
1.2
1.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
4.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
61
0.98
0.00
1.0
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
3.2
—
1.1
—
0
5
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4094501)
5
51
0.98
0.00
1.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
89
0.90
0.00
2.1
2.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.6
—
65.6
—
0
5
(3052851) Hemolysis interference index of Serum or Plasma
6
62
0.97
0.00
2.5
2.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint N14_ENDOMETRIOSIS_FALLOPIAN_TUBE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| N14_ENDOMETRIOSIS_FALLOPIAN_TUBE | 0.983 [0.77, 1.26] | 0.891 |
| Birth year | 0.992 [0.98, 1.0] | 0.061 |
During the follow-up period (1.1.1998 — 31.12.2019), 62 out of 1244 females with N14_ENDOMETRIOSIS_FALLOPIAN_TUBE died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have N14_ENDOMETRIOSIS_FALLOPIAN_TUBE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.092% | No data |
| 5 | 0.464% | No data |
| 10 | 1.202% | No data |
| 15 | 2.489% | No data |
| 20 | 4.428% | No data |
Relationships between endpoints
↥Index endpoint: N14_ENDOMETRIOSIS_FALLOPIAN_TUBE – Endometriosis of fallopian tube
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data